title: Normal pregnancy in a patient with β-thalassaemia major receiving iron chelation therapy with deferasirox (Exjade®).
authors.forename: Dimitra
authors.initials: D
authors.lastname: Vini
authors.forename: Philippos
authors.initials: P
authors.lastname: Servos
authors.forename: Marouso
authors.initials: M
authors.lastname: Drosou
mesh_terms: D000328:Adult; D001565:Benzoates / Q000627:therapeutic use*; D000075202:Contraindications; D000077588:Deferasirox; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007502:Iron Chelating Agents / Q000627:therapeutic use*; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000188:drug therapy*; D011256:Pregnancy Outcome; D014230:Triazoles / Q000627:therapeutic use*; D017086:beta-Thalassemia / Q000150:complications* / Q000188:drug therapy*
chemical_list: D001565:Benzoates; D007502:Iron Chelating Agents; D014230:Triazoles; D000077588:Deferasirox